Lv1
72 积分 2025-08-20 加入
Engineering CD3/CD137 Dual Specificity into a DLL3-Targeted T-Cell Engager Enhances T-Cell Infiltration and Efficacy against Small-Cell Lung Cancer
2小时前
待确认
Reducing affinity as a strategy to boost immunomodulatory antibody agonism
4天前
已完结
Cathepsin B: The dawn of tumor therapy
18天前
已完结
A recombinant polypeptide extends the in vivo half-life of peptides and proteins in a tunable manner
1个月前
已完结
IMT030122, A novel engineered EpCAM/CD3/4-1BB tri-specific antibody, enhances T-cell recruitment and demonstrates anti-tumor activity in mouse models of colorectal cancer
1个月前
已完结
A next generation mathematical model for the in vitro to clinical translation of T-cell engagers
2个月前
已完结
Treatment of metastatic renal cell carcinoma (mRCC) with CAIX CAR-engineered T-cells–a completed study overview
2个月前
已完结
Mutational landscape and clinical implications of VHL in clear cell renal cell carcinoma: a multi-dataset analysis of 1377
2个月前
已完结
Quantification of Carbonic Anhydrase IX Expression in Serum and Tissue of Renal Cell Carcinoma Patients Using Enzyme-linked Immunosorbent Assay: Prognostic and Diagnostic Potentials
2个月前
已完结
皖公网安备34019202002308
